European Companies Search Engine

EU funding (€10.6M): Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe Hor29 Dec 2022 EU Research and Innovation programme "Horizon"

Text

Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

EUonQoL aims to develop, pilot and validate the EUonQoL-Kit, a patient-driven, unified system for the assessment of quality of life (QoL) based on evaluations and preferences of cancer patients and survivors. The EUonQoL-Kit will be developed from a patient perspective, administered digitally, available in the EU27 and Associated countries languages, and applicable in future, periodic surveys to contribute to the EU’s mission on cancer. At the core of the EUonQoL there is the adoption of a multistakeholder, co-design methodology, engaging patient representatives, healthcare professionals, administrators, policymakers, and citizens in all project related activities. Existing QoL tools will be reviewed, scoping all relevant sources. This review will be used in the context of the codesign consensus with stakeholders’ and patients’ preferences to identify gaps and establish all QoL dimensions that are relevant from the perspectives of patients, clinicians, and society. A multidisciplinary researcher panel, composed by the most talented experts, will develop the EUonQoL-Kit that will be validated in a pilot survey using digital data collection within month 24 of the project. A total of 4,000 cancer patients and survivors will be enrolled through a network of EU cancer centers. An analysis of factors potentially impacting on cancer patients and survivors QoL, will also be performed. Implementation and exploitation strategies, as well as the linkage with other Cancer Mission projects and actions will be explored to develop future periodic surveys. EUonQoL is composed by research institutions, cancer centers, as well as scientific, professional, and patient representative organizations involved in cancer research, all with extensive experience and robust scientific background in the development of self-report QoL measures.This partnership fuels the ambition of EUonQoL to translate QoL information into future changes in cancer care policy and clinical practice.


Funded Companies:

Company name Funding amount
The Leeds Teaching Hospitals National Health Service Trust ?
Alleanza Contro IL Cancro €0.00
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG €246,000
Digital Institute for Cancer Outcomes Research €655,170
European Association for Palliative Care €101,541
European Cancer Organisation €485,375
European Organisation for Research AND Treatment OF Cancer Aisbl €583,000
Federatia Asociatiilor Bolnavilor de Cancer €31,750
Federazione Italiana Delle Associazioni Di Volontariato IN Oncologia €127,375
Fondazione Irccs Istituto Nazionale DEI Tumori €1,961,272
Fundacio Institut Hospital del Mar D Investigacions Mediques €462,099
Institut Curie €152,143
Institut Gustave Roussy €288,625
Istituti Fisioterapici Ospitalieri €0.00
Istituto Europeo Di Oncologia Srl €703,900
ISTITUTO NAZIONALE TUMORI Fondazione Pascale €0.00
Medizinische Universitat Innsbruck €141,750
Organisation OF European Cancer Institutes €1,694,340
Oslo Universitetssykehus HF €749,375
Region Hovedstaden €616,584
SDRUZHENIE ASOTSIATSIA NA PATSIENTITE S ONKOLOGICHNI ZABOLYAVANIA I PRIYATELI €31,750
SPOREDATA OÜ €145,831
STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS €172,896
STICHTING NEDERLANDS INSTITUUT VOOR ONDERZOEK VAN DE GEZONDHEIDSZORG €859,801
Unicancer €198,938
Universita Degli Studi Di Milano €197,796

Source: https://cordis.europa.eu/project/id/101096362

The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: The Leeds Teaching Hospitals National Health Service Trust, Leeds.

Creative Commons License The visualizations for "The Leeds Teaching Hospitals National Health Service Trust - EU funding (€10.6M): Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.